Acción CUBT CURATIVE BIOTECHNOLOGY, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Curative Biotechnology, Inc.

Acciones

CUBT

US23128N1081

Precio de cierre OTC Markets
Otros sitios de cotización
 00:00:00 13/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,019 USD 0,00 % Gráfico intradía de Curative Biotechnology, Inc. +4,40 % -10,80 %
06/05 Curative Biotechnology, Inc. informa de los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
2023 Curative Biotechnology, Inc. ha retirado su OPV por un importe de 7,999998 millones de dólares. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CUBT
  4. Noticias Curative Biotechnology, Inc.
  5. Otros idiomas